시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 환자 혈액 관리 시장 보고서(2024년)
Patient Blood Management Global Market Report 2024
상품코드 : 1426235
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,000 ￦ 7,234,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,500 ￦ 10,851,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 10,000 ￦ 14,469,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

환자 혈액 관리 시장 규모는 향후 몇 년 동안 크게 성장할 것으로 예상됩니다. 2028년에는 6.4%의 연평균 복합 성장률(CAGR)로 190억 7,000만 달러 규모로 성장할 것으로 예상됩니다. 예측 기간 동안 예상되는 성장은 인구 고령화, 혈액제제 수요 증가, 인구 통계학적 변화, 개인 맞춤형 의료에 대한 관심 증가, 안전하고 효율적인 수혈 관행에 대한 수요 증가, 혈액제제에 대한 수요 증가 등 몇 가지 중요한 요인과 관련이 있을 수 있습니다. 의료 비용 중. 이 기간 동안 예상되는 주요 트렌드에는 환자 중심의 치료 접근 방식, 데이터 중심의 의사 결정 프로세스, 헤모글로빈 수준 최적화, 공동 치료 모델, 자가 혈액 방법의 사용 확대에 대한 초점이 포함됩니다.

세계 환자 혈액 관리 시장은 사고, 외상 및 수술의 증가로 인해 성장세를 보이고 있습니다. 세계보건기구(WHO)는 교통 사고로 인한 연간 사망자 수가 135만 명에 달하며, 중저소득 국가가 이 사망자 수의 93%를 차지한다고 보고했습니다. 마찬가지로 2021년 질병통제예방센터는 제왕절개 출산율이 전체 출생아의 32.1%에 달한다고 발표했습니다. 이 사건의 급증으로 인해 혈액 및 그 파생 상품에 대한 수요가 증가하여 시장 성장을 크게 촉진하고 있습니다.

환자 혈액 관리 시장이 확대될 것으로 예상되는 이유는 수혈의 필요성이 증가하고 있기 때문입니다. 환자 혈액 관리에서 중요한 수혈은 전혈 또는 그 성분을 환자에게 옮기는 것을 포함합니다. 이는 수술, 헤모글로빈 장애, 빈혈 치료, 수술 전/후 관리에서 매우 중요한 역할을 합니다. 영국 정부는 2021년 헌혈자 수가 170만 명으로 증가했다고 기록했으며, 이는 수혈에 대한 수요 증가가 시장 성장을 주도하고 있음을 보여줍니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

제5장 세계 시장 규모와 성장

제6장 시장 세분화

제7장 지역 및 국가 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 상황과 기업 개요

제31장 경쟁 벤치마킹

제32장 경쟁 대시보드

제33장 주요 인수합병

제34장 향후 전망과 가능성 분석

제35장 부록

ksm
영문 목차

영문목차

Patient blood management is a patient-centric and evidence-based strategy designed to optimize patient care, particularly for those potentially requiring blood transfusions. It aims to enhance patients' own blood, minimize blood loss during surgeries, and utilize the body's natural reserves to manage anemia, ultimately reducing the reliance on external blood transfusions.

Within patient blood management, products are categorized into instruments, accessories, reagents, kits, and software. These kits play a role in managing a patient's blood. Additionally, patient blood management is categorized by blood components such as plasma, whole blood, and red blood cells, utilized across various healthcare settings including hospitals, clinics, and other medical facilities.

The patient blood management market research report is one of a series of new reports from The Business Research Company that provides patient blood management market statistics, including patient blood management industry global market size, regional shares, competitors with a patient blood management market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the patient blood management industry. This patient blood management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The patient blood management market size has grown strongly in recent years. It will grow from $13.83 billion in 2023 to $14.86 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth observed in the historical period can be attributed to several factors, including a rising prevalence of chronic diseases, a growing number of surgical procedures being performed, governmental initiatives promoting healthcare, an increased demand for bloodless surgical techniques, the availability of blood substitutes, and a heightened demand for improved quality in healthcare services.

The patient blood management market size is expected to see strongly grown in the next few years. It will grow to $19.07 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. Anticipated growth in the forecast period can be linked to several key factors, including an aging population, an increased demand for blood products, shifting demographics, a growing emphasis on personalized medicine, a heightened demand for safe and efficient blood transfusion practices, and a rise in healthcare expenditures. Major trends expected during this period encompass a focus on patient-centered care approaches, data-centric decision-making processes, optimizing hemoglobin levels, collaborative care models, and an expanded utilization of autologous blood methods.

The global patient blood management market has seen growth owing to increased accidents, trauma cases, and surgical procedures. The World Health Organization reports an annual death toll of 1.35 million due to road accidents, with low and middle-income countries accounting for 93% of these fatalities. Similarly, in 2021, the Centers for Disease Control and Prevention noted a cesarean birth rate of 32.1% of total births. This surge in incidents has led to heightened demand for blood and its derivatives, significantly driving market growth.

Anticipated market expansion in patient blood management is attributed to the escalating need for blood transfusions. Blood transfusions, crucial in patient blood management, involve the transfer of whole blood or its components to patients. They play pivotal roles in surgeries, treating hemoglobin disorders, anemia, and pre/postoperative care. In 2021, the UK government recorded an increase in blood donations to 1.7 million, indicative of the rising demand for transfusions propelling the market growth.

HEMAsavR, a sterile medical device, is increasingly adopted for capturing and transferring blood in surgical settings to respond swiftly to unforeseen blood loss. This device allows clinicians to collect anticoagulated blood economically without specialized resources, reducing upfront collection costs and potentially avoiding allogenic transfusions. Its use correlates with improved patient outcomes including reduced mortality rates, lower infection incidents, and decreased risk of multi-organ failure.

Key players within the patient blood management market concentrate on innovative products, particularly medical devices facilitating blood transfusions, to bolster revenues. These devices are designed for the safe and efficient transfer of blood or its products between donors and recipients. For instance, in April 2021, EryPharm, a France-based pharmaceutical company specializing in blood management devices, introduced a device aimed at mass-producing cultured red blood cells. This innovation addresses the needs of patients requiring multiple transfusions or affected by conditions impacting red blood cells, potentially enhancing their quality of life.

Major companies operating in the patient blood management market include Haemonetics Corporation, Fresenius SE & Co. KGaA, Terumo Corporation, Immucor Inc., B. Braun Melsungen AG, Macopharma, bioMerieux SA, Asahi Kasei Corporation, KANEKA CORPORATION, Bio-Rad Laboratories Inc., Abbott Laboratories, Grifols, Roche, LIVANOVA PLC, Danaher, Mediware information systems, Kawasumi Laboratories, Haier Biomedical, Diatron MI Zrt., BAG Diagnostics GmbH, Hitachi Ltd., Ortho Clinical Diagnostics, Beckman Coulter Inc., Siemens Healthineers, Thermo Fisher Scientific Inc., Sysmex Corporation, Nihon Kohden Corporation, Radiometer Medical ApS, Instrumentation Laboratory, F. Hoffmann-La Roche Ltd., Grifols Diagnostic Solutions Inc., HemoCue AB, Immucor GTI Diagnostics

North America was the largest region in the patient blood management market in 2023. Western Europe was the second-largest region in the patient blood management market share. The regions covered in the patient blood management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the patient blood management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The patient blood management market includes revenues earned by instruments, blood processing devices, and centrifuges. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Patient Blood Management Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on patient blood management market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for patient blood management? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The patient blood management market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

Table of Contents

1. Executive Summary

2. Patient Blood Management Market Characteristics

3. Patient Blood Management Market Trends And Strategies

4. Patient Blood Management Market - Macro Economic Scenario

5. Global Patient Blood Management Market Size and Growth

6. Patient Blood Management Market Segmentation

7. Patient Blood Management Market Regional And Country Analysis

8. Asia-Pacific Patient Blood Management Market

9. China Patient Blood Management Market

10. India Patient Blood Management Market

11. Japan Patient Blood Management Market

12. Australia Patient Blood Management Market

13. Indonesia Patient Blood Management Market

14. South Korea Patient Blood Management Market

15. Western Europe Patient Blood Management Market

16. UK Patient Blood Management Market

17. Germany Patient Blood Management Market

18. France Patient Blood Management Market

19. Italy Patient Blood Management Market

20. Spain Patient Blood Management Market

21. Eastern Europe Patient Blood Management Market

22. Russia Patient Blood Management Market

23. North America Patient Blood Management Market

24. USA Patient Blood Management Market

25. Canada Patient Blood Management Market

26. South America Patient Blood Management Market

27. Brazil Patient Blood Management Market

28. Middle East Patient Blood Management Market

29. Africa Patient Blood Management Market

30. Patient Blood Management Market Competitive Landscape And Company Profiles

31. Global Patient Blood Management Market Competitive Benchmarking

32. Global Patient Blood Management Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Patient Blood Management Market

34. Patient Blood Management Market Future Outlook and Potential Analysis

35. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기